Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat

Clinical Microbiology Reviews

Volumn 14, Issue 4, 2001, Pages 933-951

  Bradford, P A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PHYLOGENY; SUBSTRATE SPECIFICITY;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0034763241     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.4.933-951.2001     Document Type: Review

References (191)

1. An enzyme from bacteria able to destroy penicillin
2. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanii
3. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae
4. The structure of β-lactamases
5. A standard numbering scheme for the class A β-lactamases
6. Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases
7. Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB)
8. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme
9. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca
10. Distinction entre les structures primaires des β-lactamases TEM-1 et TEM-2
11. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium
12. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
13. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases
14. PER-2, which encodes an extended-spectrum class A Β-lactamase
15. Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia
16. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)
17. Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital
18. Selection of naturally occurring extended-spectrum TEM β-lactamase variants by fluctuating β-lactam pressure
19. Diversity of TEM mutants in Proteus mirabilis
20. A novel class A extended-spectrum β-lactamase (BES-1) in Serrattia marcescens isolated in Brazil
21. A novel CTX-M β-lactamase (CTX-M-8) in cefotaximeresistant Enterobacteriaceae isolated in Brazil
22. OHIO-1 β-lactamase resistant to mechanism-based inactivators
23. Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases
24. OXA-24, a novel class D β-lactmase with carbapenemase activity in an Acinetobacter baumannii clinical strain
25. SHV genes
26. Multiply resistant Klebsiella pneumoniae strains from two Chicago Hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate
27. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients
28. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase and the loss of an outer membrane protein
29. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia
30. Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases in a university hospital
31. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains
32. A functional classification scheme for β-lactamases and its correlation with molecular structure
33. Biochemical characteristics of extended broad spectrum β-lactamases
34. Ceftriaxone-sulbactam combination in a rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended broadspectrum TEM-3 β-lactamase
35. Detection of extended-spectrum β-lactamases in klebsiellae with the Oxoid combination disk method
36. Incidence of strains producing extended-spectrum β-lactamase in Argentina
37. Inhibitor-resistant TEM-β-lactamases: Phenotypic, genetic and biochemical characteristics
38. Characterization of extended-spectrum β-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP)
39. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen
40. Invasive disease due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: The possible role of cockroaches
41. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center: Seek and you may find
42. Genotypic approach to the study of bacterial resistance to antibiotics
43. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital
44. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa
45. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa
46. OXA-15, an extended-spectrum variant of OXA-2 β-lactamase, isolated from a Pseudomonas aeruginosa strain
47. OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates
48. Penicillinase synthesis controlled by infectious R Factors in Enterobacteriaceae
49. A pilot study of antibiotic cycling in a hematology-oncology unit
50. First isolation of a CTX-M-3-producing Enterobacter cloacae in France
51. Molecular epidemiology of a nosocomial outbreak due to SHV-4 producing strains of Citrobacter diversus
52. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center
53. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase
54. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel
55. Digoxigenin-labeled DNA probe to detect TEM type β-lactamases
56. Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolysing class A β-lactamase CTX-M-4
57. A plasmid-mediated β-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St. Petersburg, Russia
58. Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium
59. Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A β-lactamase (CTX-M-4): Involvement of serine 237 in cephalosporin hydrolysis
60. Serine β-lactamases and penicillin-binding proteins
61. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: Clonal spread of the TEM-47 extended-spectrum β-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene
62. Ceftazidime-resistant Enterobacteriaceae isolates from three polish hospitals: Identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases
63. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: Identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M1/MEN-1 enzyme
64. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa
65. Molecular characterization of nine different types of mutants among 107 inhibitorresistant TEM β-lactamases from clinical isolates of Escherichia coli
66. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae
67. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong
68. Role of Ser-238 and Lys-240 in the hydrolysis of 3rd-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and 3-dimensional modeling
69. Detection of plasmidmediated β-lactamases with DNA probes
70. Crystal structure of the E166A mutatant of extended-spectrum β-lactamase Toho-1 at 1.8 Å resolution
71. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli
72. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
73. More extended-spectrum β-lactamases
74. Properties of plasmids responsible for production of extended-spectrum β-lactamases
75. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
76. The microbial genetics of antibiotic cycling
77. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases
78. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: Prevalence of SHV-12 and SHV-2a in Korea
79. Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction
80. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
81. TEM genes
82. First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae strains
83. Survey of the prevalence of β-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital
84. β-lactamases in laboratory and clinical resistance
85. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe
86. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital
87. Cloning and sequencing of the gene encoding Toho-2, a class A β-lactamase preferentially inhibited by tazobactam
88. Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae
89. PCR detection and identification of genes for extended-spectrum β-lactamases
90. TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient
91. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expandedspectrum cephalosporins
92. Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins
93. Characterization of SFO-1, a plasmidmediated inducible class A β-lactamase from Enterobacter cloacae
94. Plasmid-mediated Betalactamases
95. β-lactamases
96. Comparative susceptibility of clinical isolates producing extended-spectrum beta-lactamases to ceftibuten: Effect of a large inoculum
97. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins
98. Emergence of clinical isolates with decreased susceptibility to ceftazidime and synergistic effect with co-amoxiclav due to SHV-1 hyperproduction
99. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
100. New extended spectrum TEMtype β-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak
101. Novel OXA10-derived extended-spectrum β-lactamases selected in vivo or in vitro
102. A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa
103. Carbapenems as inhibitors of OXA-13, a novel integron-encoded β-lactamase in Pseudomonas aeruginosa
104. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the MAST DD test, the double disc and the Etest ESBL
105. PCR single strand conformational polymorphism can be used to detect the gene encoding SHV-7 extended-spectrum β-lactamase and to identify different SHV genes within the same strain
106. Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP)
107. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa
108. Molecular characterization of In50, a class1 integron encoding the gene for the extendedspectrum β-lactamase VEB-1 in Pseudomonas aeruginosa
109. Molecular characterization of OXA-20, a novel class D β-lactamase, and its integron from Pseudomonas aeruginosa
110. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients
111. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa
112. Trends in β-lactam resistance among Enterobacteriaceae
113. Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D β-lactamase from Ralstonia (Pseudomonas) pickettii
114. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the Etest
115. Oligonucleotide probes (TEM-1, OXA-1) versus isoelectric focusing in β-lactamase characterization of 114 resistant strains
116. TREEVIEW: An application to display phylogenetic trees on personal computers
117. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea
118. New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis
119. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase
120. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia
121. Extended-spectrum β-lactamases: A call for improved detection and control
122. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae
123. Epidemiology an successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases
124. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase in the intensive care unit
125. Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain
126. TEM-72, a new extendedspectrum β-lactamase detected in Proteus mirabilis and Morganella morganii in Italy
127. Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?
128. Systematic mutagenesis of the activesite omega loop of TEM-1 beta-lactamase
129. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa
130. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Are β-lactamase inhibitors of therapeutic value?
131. β-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa
132. OXA-28, an extended-spectrum variant of OXA-10, β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene
133. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene
134. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron IN52 from Klebsiella pneumoniae
135. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant
136. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
137. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia
138. Successful interventions for gram-negative resistance to extended-spectrum β-lactam antibiotics
139. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae
140. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
141. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility
142. Efficacy of different β-lactams against an extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model
143. The β-lactamases of gram-negative bacteria and their possible physiological role
144. Capnocytophaga ochracea: Characterization of a plasmidencoded extended-spectrum TEM-17 β-lactamase in the phylum Flavobacter-Bacteroides
145. CME) encoding an extended-spectrum class A β-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases
146. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain
147. Detection of extendedspectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test
148. Ability of the VITEK 2 Advanced Expert system to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa
149. A hospital outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance
150. Extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom
151. TLA-1: A new plasmid-mediated extendedspectrum β-lactamase from Escherichia coli
152. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate
153. β-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase. OXA-30
154. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: Prevalence of TEM-3 and first identification of TEM-26 in France
155. The TEM-3 β-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions
156. Novel β-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to β-lactam antibiotics
157. Construction and characterization of mutants of the TEM-1 β-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to β-lactamase inhibitors
158. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of Project ICARE laboratories
159. Occurrence of extended-spectrum beta-lactamases in Dutch hospitals
160. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322
161. Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase in the premature intensive care unit of a Hungarian hospital
162. Detection and reporting of organisms producing extended-spectrum β-lactamases: Survey of laboratories in Connecticut
163. Ability of laboratories to detect emerging antimicrobial resistance: Proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing
164. Molecular characterization of a TEM-21 β-lactamase in a clinical isolate of Morganella morganii
165. Biotinylated oligonucleotide probes for the detection and characterization of TEMtype extended-spectrum β-lactamases in Enterobacteriaceae
166. The CLUSTAL-X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools
167. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests
168. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens
169. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes
170. SHV-type β-lactamases
171. Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: Report of the first three cases
172. CTX-M-type β-lactamases: An emerging group of extended-spectrum enzymes
173. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae
174. Characterization of multiple-antibiotic-resistant Salmonella typhimurium strains: Molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone
175. Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase, in Salmonella typhimurium from Istanbul, Turkey
176. Practical approach for detection and identification of OXA-10derived ceftazidime-hydrolyzing extended-spectrum β-lactamases
177. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicenter study
178. pUC19 β-lactamase on susceptibility to β-lactams
179. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece
180. Characterization of TEM-1 beta-lactamase mutants from positions 238-241 with increased catalytic efficiency for ceftazidime
181. Comparison of screening methods for the detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital
182. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii
183. Molecular epidemiology as an effective tool in the surveillance of infections in the neonatal intensive care unit
184. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes
185. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan
186. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan
187. Ceftazidime-resistant Klebsiella pneumoniae and E. coli isolates producing TEM-10 and TEM-43 from St. Louis
188. Epidemiological typing of kebsiellae with extended-spectrum β-lactamases from European intensive care units
189. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivtives or an OXA-1 β-lactamase conferring resistance to β-lactamase inibitors